iRadimed
IRMD
65 hedge funds and large institutions have $105M invested in iRadimed in 2020 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 32 increasing their positions, 16 reducing their positions, and 13 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 16
20% more capital invested
Capital invested by funds: $87.2M → $105M (+$17.5M)
3.13% more ownership
Funds ownership: 34.31% → 37.44% (+3.1%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
6% less funds holding
Funds holding: 69 → 65 (-4)
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
+$2.98M |
| 2 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$1.71M |
| 3 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
+$1.59M |
| 4 |
BlackRock
New York
|
+$1.39M |
| 5 |
Renaissance Technologies
New York
|
+$1.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.25M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$809K |
| 3 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$701K |
| 4 |
AG
Algert Global
San Francisco,
California
|
-$644K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$500K |
IRMD Hedge Fund Activity: Q2 2020 in Review
65 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q2 2020, worth a combined $105M — up 20% from $87.2M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of IRMD and 9 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 32 added.
The largest buyer was Nine Ten Capital Management, adding an estimated $2.98M. The largest seller was Millennium Management, exiting entirely with an estimated $1.25M sold.
- 65 institutional investors held iRadimed (IRMD) as of Q2 2020, down from 69 in Q1 2020.
- Funds reported $105M of iRadimed stock for Q2 2020, up 20% quarter-over-quarter.
- 9 funds opened new iRadimed positions in Q2 2020 and 13 closed out, a net change of -4 holders.
- The largest iRadimed buyer in Q2 2020 was Nine Ten Capital Management, an estimated $2.98M added.
- The largest iRadimed seller in Q2 2020 was Millennium Management, an estimated $1.25M sold.
Based on aggregated 13F filings for Q2 2020.